Vanesa Ortega
AuthID: R-00H-YME
1
TITLE: Phase II, Multicenter, Single-arm Trial of Eribulin as First-line Therapy for Patients With Aggressive Taxane-pretreated HER2-Negative Metastatic Breast Cancer: The MERIBEL Study Full Text
AUTHORS: Vanesa Ortega; Antonio Anton; Isabel Garau; Nomia Afonso; Lourdes Calvo; Yolanda Fernandez; Maria Martinez Garcia; Esperanza Blanco; Pilar Zamora; Mirta Garcia; Jose J Juan Illarramendi; Csar Augusto R Rodrguez Sanchez; Miguel Sampayo; Elena Aguirre; Jose M Manuel Perez Garcia; Javier Cortes; Antonio Llombart Cussac;
PUBLISHED: 2019, SOURCE: CLINICAL BREAST CANCER, VOLUME: 19, ISSUE: 2
AUTHORS: Vanesa Ortega; Antonio Anton; Isabel Garau; Nomia Afonso; Lourdes Calvo; Yolanda Fernandez; Maria Martinez Garcia; Esperanza Blanco; Pilar Zamora; Mirta Garcia; Jose J Juan Illarramendi; Csar Augusto R Rodrguez Sanchez; Miguel Sampayo; Elena Aguirre; Jose M Manuel Perez Garcia; Javier Cortes; Antonio Llombart Cussac;
PUBLISHED: 2019, SOURCE: CLINICAL BREAST CANCER, VOLUME: 19, ISSUE: 2
INDEXED IN: 
Scopus 
WOS
Scopus WOS